In-vitro Colorectal Cancer Screening Tests (Fecal Occult Tests: Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA; Stool Biomarker Tests: ColoGuard, M2-PK Stool Test, and Others; Blood Biomarker Tests: ColonSentry, ColoVantage, Epi proColon, mS9, and Others) Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023



Transparency Market Research

$ 5795

In Stock

Colorectal cancer, also known as bowel cancer, colorectal adenocarcinoma, or colon cancer, is a type of cancer that results from uncontrolled growth of the cells of rectum or colon. Factors such as growing geriatric population, rising prevalence of colorectal cancer, technological advancement, introduction of non-invasive screening tests are driving the growth of the global in-vitro colorectal cancer screening tests market. This report studies the current scenario as well as future market potential for in-vitro colorectal cancer screening tests globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global in-vitro colorectal cancer screening tests market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter